"Asheville Neurology accepts patients through referring physicians who trust us to provide a high level of expertise and innovative neurological care. We provide that care in a compassionate way, treating each patient with respect and courtesy. We offer consultative, diagnostic, treatment services and ongoing care for nervous system disorders, including conditions such as Epilepsy, Parkinson’s, Multiple Sclerosis, neuropathy, headaches and other brain, spinal cord, nerve and muscle diseases."

During the past decade, Asheville Neurology Specialists, PA conducted 13 clinical trials. In the 10-year time frame, 13 clinical trials started and 14 clinical trials were completed, i.e. on average, 107.7% percent of trials that started reached the finish line to date. In the past 5 years, 5 clinical trials started and 8 clinical trials were completed. i.e. 160% of trials that started reached the finish line.

Out of the total clinical trials conducted in "Asheville Neurology Specialists, PA" #1 sponsor was "Pfizer" with 5 trials, followed by "Eisai Inc." with 4 trials sponsored, "Eli Lilly and Company" with 3 trials sponsored, "GlaxoSmithKline" with 2 trials sponsored and "Intec Pharma Ltd." with 2 trials sponsored. Other sponsors include 6 different institutions and companies that sponsored additional 15 trials in total.

In terms of collaborators to trials, out of the total clinical trials conducted in "Asheville Neurology Specialists, PA" #1 collaborator was "CoLucid Pharmaceuticals" with 2 trials as a collaborator, "Acorda Therapeutics" with 1 trials as a collaborator, "Bausch Health Americas, Inc." with 1 trials as a collaborator and "Novotech Health Holdings Pte. Ltd." with 1 trials as a collaborator. Other collaborators include -4 different institutions and companies that were collaborators in the rest 4 trials.

According to Clinical.Site data, the most researched conditions in "Asheville Neurology Specialists, PA" are "Parkinson's Disease" (5 trials), "Epilepsy" (2 trials), "Migraine Disorders" (2 trials), "Osteoarthritis" (2 trials) and "Alzheimer Disease" (1 trials). Many other conditions were trialed in "Asheville Neurology Specialists, PA" in a lesser frequency.

Most popular intervention types in "Asheville Neurology Specialists, PA" are "Drug" (23 trials), "Biological" (5 trials), "Other" (3 trials) and "Combination Product" (1 trials). Other intervention types were less common.

The name of intervention was led by "Placebo" (10 trials), "placebo" (3 trials), "Accordion Pill™ Carbidopa/Levodopa" (2 trials), "Rufinamide" (2 trials) and "Tanezumab" (2 trials). Other intervention names were less common.

The vast majority of trials in "Asheville Neurology Specialists, PA" are 27 trials for "All" genders.

Currently, there are NaN active trials in "Asheville Neurology Specialists, PA". undefined are not yet recruiting, 3 are recruiting, 2 are Active, not recruiting, and undefined are Enrolling by invitation. In total, there were 13 completed trials in Asheville Neurology Specialists, PA, undefined suspended trials, and 6 terminated clinical trials to date.

Out of the total trials that were conducted in Asheville Neurology Specialists, PA, 0 "Phase 1" clinical trials were conducted, 6 "Phase 2" clinical trials and 19 "Phase 3" clinical trials were conducted as well. "Phase 4" trials included 2 trials, and there were also 0 trials that are defined as “Not Applicable".